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GENERAL INTRODUCTION 
The family Caliciviridae comprises a group of small single-stranded RNA viruses that have a 
distinctive cup-shaped surface morphology and a capsid composed of a single protein . These 
features are unique among animal viruses (7, 58, 60) and are the major criteria used to define the 
family. Members of the Caliciviridae family include Vesicular exanthema of swine virus (VESV), 
San Miguel sea lion virus (SMSV), feline calicivirus (FCV), and rabbit hemorrhagic disease virus 
(RHDV) (47, 48, 57). Additional viruses with calicivirus-like morphology, or a single capsid 
protein, or both, may eventually be included in the family Caliciviridae, but none of these has as 
yet been sufficiently characterized for a definitive classification (5, 14, 15, 17, 19, 24, 25, 28, 30, 61, 
67, 68, 70). 
The study of the molecular biology of caliciviruses has been neglected in favor of other small 
RNA viruses mainly because of the relatively low impact caliciviruses have on the health of 
human and animal populations. However, in the past, caliciviruses which originated from marine 
mammals had a devastating effect on domestic swine populations with great losses to producers 
(66). According to some researchers, the reappearance of the disease is only a matter of time (63). 
Consequently, the study of the molecular aspects of these viruses has recently resumed and feline 
calicivirus has been the group model. In this regard, some progress has been made in the 
understanding of its genome organization and synthesis of specific viral induced proteins. Notably, 
the complete nucleotide sequence of one FCV strain is now available (12) and the gene encoding for 
the viral capsid protein has been identified for a number of isolates (12, 62, 74) and expressed in 
vitro (46). 
As with other viruses, the study of the early events of caliciviruses replication cycle has been 
overshadowed by a greater interest in the molecular biology of the viruses and the proteins they 
synthesize. However, as information in both fi elds accumulates, the need to understand the 
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relationship of viruses with cellular receptors has become more evident. 
This study was d esigned to further the understanding of FCV interaction with cells in culture. 
The principal objectives were: 1) Determine the optimal pH for the interaction of FCV and cellular 
receptor sites, 2) De termine the kinetics of FCV attachment to Crandell-Reese feline kidney 
(CRFK) cells in culture, 3) Determine the approximate number of virus attachment sites per cell, 
4) Determine whether diffe re nt FCV strains share the same attachment si te on the surface of CRFI< 
cells and if the interaction could be blocked by other animal calicivirus, 5) Investigate the 
biochemical nature of the receptor attachment site, and 6) Study the role specific receptor sites 
play on restricting FCV replication in nonpermissive cells. 
Explanation of Thesis Format 
This thesis includes a manuscript submitted to the Journal of Virology, in a style required by the 
American Society for Microbiology. A general introduction, objectives of s tudy and a literature 
review precede the manuscript, and a general summary follows it. Additional references cited 
fo llowing the general summary refer to citations in the general introduction and literature review. 
The M. S. candidate, Luiz Carlos Kreutz, was the principal investiga tor of the study and is the 
senior author o f the manuscript. All the experimenta l procedures reported in the ma nuscript were 
also completed by the M. S. candidate, with limited part icipation of the co-au thors. 
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REVIEW OF THE LITERATURE 
Introduction 
Caliciviruses are a group of sma ll, non-enveloped viruses that express a s ingle major capsid 
pro tein of 60 to 70 Kilod altons (58, 60). The name caliciviru s is d erived from its characteris tic cup-
shaped surface depressions observed by negative staining electron microscopy (from the Latin calyx 
= cup). Caliciviruses were formerly classified under the Picornaviridae family (27). Howe ver, 
physico-chemical properties and the strategy of RNA replication indica ted a re-classification of 
caliciviruses as a separate family, the Caliciviridae (7, 9, 22, 23, 60>. 
The recognized and characterized members of this fa mily include vesicular exanthema of swine 
virus, (VESV), San Mig ue l sea lion virus (SMSV), and feline calicivirus (FCV) (57). Recently, the 
rabbit hemorrha gic disease virus (RH DV), a nd human calici-like viruses were also included under 
the Caliciviridae family (14, 20, 47, 48). Isola tion and pa rtial cha racte ri zation of calicivirus-like 
particles from a variety of animal species has been reported (5, 14, 15, 17, 19, 24, 25, 28, 30, 61, 67, 68, 
70) but their importance as e tiological agents of specific d iseases is uncertain. 
Retrospective s tudies indicated that cal iciviruses were associa ted with the outbreaks of 
vesicular exanthema of swine (VES) in 1932. The clinical signs of VES resembled foo t-and-mouth 
disease (FMD), and the outbreaks were related to the feed ing of swine with raw garbage containing 
marine food waste (63, 66). 
Caliciviruses were first isolated from cats with respiratory disease in 1957 (26), and subsequent 
isolations were reported throug hout the world (29). Antigenically, FCV isola tes a re considered 
variants of a single serotype (6, 50, 52). 
The sea lion calicivirus, San Miguel sea lion virus (SMSV) was isolated fro m aborting sea lions in 
1972, and was in all asp ects identical to VESV (64 ). When inoculated in susceptible pigs, SMSV 
caused a disease indistinguisable from vesicular exanthema of swine (64, 69). 
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Swine calicivirus 
Vesicular exanthema of swine had its first outbreak in 1932 and it was thought to be 
foot-and-mouth disease (FMD) because of the clinical similari ties (63). VES is an acute viral 
disease caused by VES virus (VESV) and is characterized by fever and the appearance of vesicles 
on the snout, lips, tongue and mucosa of the oral cavity and on the sole, interdigital space and 
coronary band of the foot of infected animals (66). 
The outbreaks of VES were associated with the feeding of swine with uncooked garbage 
containing food waste of marine origin. Following legislation requiring the cooking of garbage fed 
to animals, VES gradually disappeared and was considered a n exotic disease in 1959 (63). 
However, as marine mammals are considered the primary source o f the virus, and serological 
studies demons trated transmission of calicivirus between marine and terrestrial animals, the 
reappearance of the disease is likely to occur (54, 63, 65, 66). 
Recently, calicivirus particles were isolated from feces of pigle ts with diarrhea (56). The virus 
was d enominated porcine enteric calicivirus (PEC) and resembled the p rototype FCV, displaying 
the characteristic cup-shaped morphology (56). Infection of gnotobiotic piglets with PEC induced 
mild to severe diarrhea that persisted fo r 3 to 7 days. No signs of vesicular disease could be 
observed and serological studies have shown that PEC is distinct from VESV (28). 
Sea lion calicivirus 
Caliciviruses were isolated from California sea lions in 1972, on San Miguel Island (64). The 
virus, called San Miguel sea lion virus (SMSV) was morphologically and biophysically identical 
to vesicular exanthema of swine virus (VESV). 
Origina lly, SMSV was isola ted from vesicular lesions of the flippers, a nd from the throat, nasal 
and rectal swabs of aborting sea lion females and their aborted fetuses and propagated in Vero 
cells. Human cells such as primary embryonic kidney and Jines of Hela, and PK-15 also supported 
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viral replication (64). Experimentally, SMSV infects monkeys and possibly humans (68). 
San Miguel sea lion virus was also isolated from ocean fishes (69) and serologic studies 
demonstrated that many marine and terrestrial animals may became infected with SMSV (54, 65). 
No information is available concerning studies on the experimental infection of sea lions with 
caliciviruses, and experimental infection o f pigs wi th SMSV is highly restricted . 
Human calicivirus 
Human candidate caliciviruses have been found associated with diarrheal and vomiting disease 
(14, 20). There are two groups of human cal icivirus: one group, which displays surface morphology 
characteristic of caliciviruses is described as human calicivirus (HCV). A second group with 
amorphous structure is referred to as small round structured viruses (SRSV) or "Norwalk-like 
agents". However, the single capsid protein in both groups has identical molecular weight (17). 
The clinical signs associated with infection by human candidate caliciviruses are similar for both 
groups. The incubation period, duration of symptoms and excretion period of detectable virus are 
also s imilar. However, HCV is more frequently associated with infections in infants whereas 
Norwalk agent is predominantly associated with disease in older children and adults (17). 
Furthermore, HCV has been replicated in cell culture, in the presence of small amounts of trypsin 
while Norwalk agent has not yet been propagated in cells in culture (18). 
Rabbit calicivirus 
Calicivirus has been implicated as the causative agent of a newly emerging hemorrhagic disease 
in rabbits (47, 48). Outbreaks of this apparently new viral disease was first reported in China in 
1984 (80) and was described as rabbit hemorrhagic disease (RHO). The disease is characterized by 
high morbidity and mortality in adult animals. Animals under the age of two months usually 
survive an infection. Oinical signs are observed 24 to 48 hours after experimental infection and are 
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characterized by fever, abdominal distention, constipation or diarrhea and hematuria. Mortality 
may be as high as 100% of infected animals. Pathological changes are observed in almost all organs 
and are characterized by petechial hemorrhage, generalized congestion and poor blood coagulation 
(80). Viruses are readily isolated from tissue speciments, mainly liver and lungs, and have not yet 
been replicated in a cell system (47, 48). 
Caliciviruses in other animal species 
The significance of calicivirus infection on a variety of animal species is not clear. The criteria 
for classification as calicivirus or calici-like virus is based on the virus structure and biophysical 
properties. Caliciviruses have been isolated from calves with respiratory tract problems in which 
virus shedding was observed over a 7 week period, demonstrating the potential of the bovids to 
become persistently infected with caliciviruses (67). Calici-like viruses (Newbury agent) have 
been isolated from calves with enteric disease and its pathogenicity was demonstrated in 
gnotobiotic calves (5). 
Caliciviruses are also implicated with enteric infection and vesicular genital disease in dogs, 
although their significance as etiological agents remains to be established (15, 24, 25,61). A chicken 
candidate calicivirus has been implicated with enteric problems in chickens and pheasants (19,30), 
and calicivirus has been isolated from a pygmy chimpanzee showing signs of upper respiratory 
disease (70). 
Feline Calicivirus 
Clinical signs and pa thogenesis 
Feline calicivirus (FCV) is widespread in the cat population and is primarily associated with 
upper respiratory tract disease. FCV was first isolated from a laboratory-induced panleucopenia 
infected, moribund ca t (26). Because of its marked cytophathogenic effect in cultured feline kidney 
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cells, the agent was designated "kidney cell-degenerating virus" (KCD), and classified 
temporarily as feline picomavirus (27). Severa l feline caliciviruses were fu rther isolated in many 
parts of the world (29), and considerable antigenic varia tion is observed by serum neutralization 
tests (6, 50, 52). Currently, FCV is considered a major health hazard to the feline respiratory 
system. 
The severity of infection caused by FCV varies according to the virulence of specific strains, and 
is generally limited to the upper respiratory tract. FCV of low virulence causes little or no clinical 
d isease, with a transient, short pyrexia (51). A typical FCV infection produces depression of 
appetite, conjunctiviti s, nasal discha rge, sneezing, coughing, and ulcerations on the tongue, hard 
palate and nostrils. A temperature response is inconsis tent and pyrexia or subnormal temperature 
may be observed (32, 51). Infection with strains of higher virulence may be followed by tracheitis, 
pneumonia and death (37). O inical signs may be observed from 2 to 10 days a fter experimental 
infection and may las t from 2 to 14 days (29). Chronic stomatitis, characterized by ulcera tive or 
proliferative lesions o n the gingiva, and occasionally on the buccal mucosa and tongue, may also be 
associated with FCV infection (39, 40). However, FCV is not a primary cause of inflammatory ora l 
lesions in cats. Rather, FCV causes stoma ti tis predominantly in cats immunocompromised by 
chronic infection with feline immunodeficiency virus (FIV) (73). 
Infection by some strains of FCV may also cause a "limping" synd rome in kittens, characterized 
by fever, vi remia and lameness. Infected kittens are reluctant to move and on clinical examination 
demonstrate hyperes thesia upon palpa tion, pain on manipulation o f joints and mild redness on the 
skin upon the a ffected joint (1 , 49). 
Feline calicivirus can be consistently isola ted from the oropharynx region of infected cats during 
the clinical phase o f the infecti on. The isolation of viruses from conjunctival and nasal swabs 
corresponds to the presence of clinical s igns (16, 78). Occasionally, FCV has a lso been isola ted from 
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rectal swabs, urine and blood samples (36, 49, 78), although viremic spread is not a consistent 
feature of caliciviruses. 
Following infection with FCV, ca ts may became persistently infected, shedding virus in 
oropharyngeal secretions for weeks, months or years after recovery from clinkal infection (53, 77, 
78). The long-term carrier state is more frequently developed in kittens exposed to non-aerosolised 
virus, when maternal antibodies decline (33, 35). Symptomless carrier cats have been implicated in 
the maintenance of FCV in the cat population. Virus transmission readily occurs to susceptible 
contacts (33, 53), and are thought to be the major cause of FCV disease outbreaks in kittens and 
breeding catteries. 
The replication of feline calicivirus in persistently infected cats is basically res tricted to the 
epithelium on the surface of the tonsils and surrounding region from which viruses can consistently 
be isolated (21 ). Chronically infected symptomless ca ts shed virus continuously d espite the 
presence of protective immune response (21 , 79). It was proposed that the sites of FCV replication 
may be partially protected fro m the immunological surveillance (53), and a ntigenically different 
viruses could ari se because of the low level of immunological pressure at the tonsilar region (21, 77, 
79). 
Pathological findings during FCV infection are mainly restricted to the o ral cavity and lungs. 
Irregularly shaped ulcers, 2 to 5 mm in diameter, with discrete defined margins may be found on the 
glossal and palatine area. Microscopically, a neutrophilic reaction is observed at the periphery 
and underneath the lesion (31, 51). Mandibular and parotid lymph nodes arc u sually enlarged and 
upon microscopic examination reveal an increase in the cellular component of the diffuse area 
around the lymphoid follicles. The Jung may show small foci of consolidation, particular at the 
apical lobe. Microscopically, consolidation areas may be plugged with cell debris including 
alveolar macrophages and neutrophils (31 , 51, 79). 
9 
Vaccination 
Little information is available concerning vaccination procedures against FCV infection. 
Currently, inactivated and live attenuated feline calicivirus vaccines, usually in combinatio n with 
feline viral rhino tracheitis (FVR), and killed feline panleucop enia (FPL) virus are u sed to confer 
protection agains t infection (2, 37, 41 , 74). 
Early vaccination experiments d emo nstrated tha t proper immunizatio n required the application 
of two doses o f the vaccine (2). Accordingly, the low virulence FCV s train F9 protected vaccinated 
ca ts against challe nge with the high virulence strain F255. The vaccine has been marketed and 
used for vaccination programmes 
Tham and Studdert (74) showed tha t a betapropiolactone-inactivated FCV vaccine was able to 
pro tect vaccinated ca ts against virus challenge six months after vaccina tion. The vaccine was 
administered twice, with 14 day intervals and had its effect potentiated by adjuvant. Vaccinated 
anima ls showed mild clinical signs and had a sho rte r period o f virus shedding than unvaccina ted 
control animals, tha t showed a severe clinical infection after virus challenge (74). However, a poor 
antibody response was obtained against a he terotypic FCV. 
A triple vaccine containing live a ttenua ted FCV, feline vira l rhino tracheitis (FVR), and killed 
feline panleucopenia (FPL) virus is also currently used. The protocol recommends two doses a t 21 
day intervals. Measurements of the antibody production in specific pathogen free (SPF) ca ts after 
vaccination and challenging procedures demonstrated tha t ca ts immunized against the triple 
commercial vaccine had pro tective levels of anti body which pro tected again st vi rus challenge a t 
21 days afte r the second vaccine dose (41). 
However, because of grea t antigenic variation among FCV, vaccines containing only one serotype 
may hasten the emergence of new serotypes and induce protection in small percentage of the 
popula tio n. Recently, it has been shown tha t immunizatio n of cats with a commercial vaccine 
containing FCV s train F9 neutralized only 54% of the field isolates, and the most cross reactive 
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field isolate neutralized only 29% of the other field isolates. Consequently, the use of polyvalent 
FCV vaccines was recommended rather than the current monovalent types (39). 
Virus isolation 
Isolation of FCV is promptly achieved in cell culture of feline origin, in which cytopathic effect 
(CPE) is observed as early as 6 hours post infection (PI). The growth curve of FCV indicates a 
maximal concentration of intracellular virus at 6 h Pl. Following cell lysis, extracellular virus 
concentration reaches a maximun at 8 h Pl. Cytopathic effect is characterized by areas of shrunken, 
rounded , refractile cells that detach freely from the monolayers. Inclusion bodies have not been 
observed in caliciviruses infected cells. Virus particles are found only in the cytoplasm, arranged 
irregularly or in linear a rrays (72). 
Viru s character istics 
Feline calicivirus is a small, non-enveloped virus which belongs to the Caliciviridae family. 
Caliciviruses range in size from 35 to 40 nm in diameter and have a buoyant density of 1.36 to 1.39 
g/ml in cesium chloride gradients (7, 71). The sedimentation coefficien t of caliciviruses range from 
160 to 207 Sin sucrose gradients (72). Members of this family possess a positive sense, 
non-segmented , polyadenylated RNA genome of 7.69 Kb (4, 12). Naked viral RNA has a 
sedimentation coefficient of 36 to 38 Sand molecular weight of 2.5 to 2.8 x 106. Total viral RNA 
comprises approximately 18% of the vi rus weight (58). A protein (VpG) of 10,000 to 15,000 Dais 
covalently attached to the 5', uncapped viral RNA genome, and is necessary to confer infectivity (8, 
59). Virus particles are roughly spherical and have a characteristic su rface morphology with 
cup-shaped depressions, from which the virus group derives its name (from the Latin calyx= cup). 
Virion particles are formed by a single major capsid polypeptide which varies in size among 
family members, but is in the range of 60,000 to 71,000 in molecular weight (7, 9, 60). 
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Virus &enome organization 
Currently, little information is available regarding the calicivirus genome organization. The 
complete sequence of the FCV strain F9 genome has recently been reported (12) and consists of 7690 
nucleotides in leng th. The virus genome contains 3 open reading frames (ORF). The larger, ORF I 
encodes for non-structural proteins and extends from position 2 to 5308. The initiation codon in the 
viral RNA of this ORF is located at position 20, and encodes for a polypeptide of 1763 amino acids 
(12). The region encoding for the non-structural proteins was previously partially sequenced and 
characterized (43). The amino acid sequence of this region revealed a high degree of similarity 
with the 3C cysteine protease, 2C polypeptide and 30 RNA-dependent RNA polymerase of 
picomaviruses. These proteins are located at the C-terminus of the FCV nonstructural polypeptide. 
A 40 KDa region located between the FCV 2C and 3C protease-like polypeptides, tha t have no 
amino acid sequence similarities to any picornavirus protein was also reported (43). 
At the 3' end of the FCV genome, ORF II extends from residues 5314 to 7362 and encodes for a 671 
amino acid polypeptide (12). Sequence ana lysis for the 3' end of the genome were also completed for 
FCV strain F4 (76), CFI-68 (46), KCD and NADC (62). In these strains, ORF II contains 2004 
nucleotides and encodes a protein of 668 amino acids, which differs primarily in the E region among 
different strains. This ORF encodes for the capsid protein (46). The capsid protein gene is currently 
the only gene well characterized in ca liciviruses. A small ORF III is located at the extreme 3' end 
of the viral genome and extends from position 7362 to 7644 (12). Protein synthesis from this ORF 
has not yet been demonstrated. However, the p redicted amino acid sequence of this product argues 
for a func tional role as a small nucleic acid binding protein comparable to plant RNA viruses (46). 
This protein may be synthesized in fusion with the capsid protein by a -1 frameshift. Such a 
mechanism would allow regulated translation of specific peptides required a t much lower copy 
number than the capsid protein (46). However, this hypothesis needs to be confirmed. Following 
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the stop codon o f the third ORF, there are 40 to 50 non translated nucleotides before the poly (A) 
tail (12, 46, 76). 
The nucleotide sequence of a calicivirus candidate, the RHDV, has also been reported . The 
complete nucleotide sequence encompasses 7437 residues (42) and reveals a considerable degree of 
similarity and homology with the overall sequence with FCV. A major difference between the FCV 
and RHDV genome sequence concerns the number of ORFs. The RHDV genome has two ORFs. The 
first ORF starts with ATG at position 10-12 ending at position 7042-7044. The coding capacity of 
this ORF is for 2344 amino acid (257 KDa protein). A second, small ORF its located at the 3' end, 
overlapping the first ORF in 17 nucleotides and consists of 351 residues. The capsid protein of 
RHDV is encoded by the 3' region , and is synthesized as a fusion protein with the non-structural 
proteins (42). Furthermore, the non-structural pro teins encoded for by the 5' region also show a high 
degree of similarity with FCV proteins. Accordingly, the 5' end of RHDV genome encodes for a 
picomavirus 2C-like domain, a not yet characterized protein, a cysteine protease and finally the 
RNA polymerase. 
Virus specific RNAs 
Currently, the number and forms of virus-specific RN As in feline calicivirus infected cells a rc not 
well characterized. However, it is well known that FCV mRNAs are synthesized as a 3' 
co-terminal nested set of subgenomic molecules (3, 11, 45). The number of proteins syn thesized in 
FCV infected cells far exceeds the coding capacity of the mRNAs observed in the infectious cycle. 
Currently, it is accepted tha t a full length complementary RNA is the first molecule synthesized 
from the incoming viral genome (11). Subgenomic RNAs arc transcribed from this negative sense 
genomic RNA and subsequently syn thesized in their negative fonn. These transcripts are then 
replicated independently via nega tive s tranded forms (11 , 45). Viral RNAs synthesized in infected 
cells are, in order of size, the 7.6 Kb genomic RNA, and species of 5.3 Kb, 4.3 Kb, 3.6 Kb, the capsid 
13 
subgenomic RNA of 2.4 to 2.7 Kb, 1.9 Kb, 1.5 Kb and a small transcript of 550 nucleotides (11, 45). 
The 2.4 to 2.7 Kb transcript is the most abundant subgenomic RNA synthesized and encodes the FCV 
capsid protein (45, 46). No pro teins are yet identified with the remaining subgenomic RN As. The 
1.9 Kb, 15 Kb and 550 nucleotides transcripts have no negative sense counterpart (12). The 
mechanisms and strategy of transcription are not yet fully characterized. However, the synthesis 
of subgenomic RNAs provides a fas t and powerful mechanism of amplification, which is 
responsible for the rapid accumulation of positive sense RNA species observed approximately at 
2 hr post infection onward, which coincides with the time when viral encoded proteins begin to be 
synthesized. 
Virus specific proteins 
The synthesis of proteins in FCV infected cells is also not well characterized. Proteins 
synthesized during the replication cycle are under a temporal regulation which may be divided 
into two phases (10). The early phase is characterized by the synthesis of 2 pro teins, of 75,000 and 
73,000 in molecular weight, respectively. The function of these proteins is still unknown. The 
second, late phase begins at approximately 3 hr post infection and coincides with a rapid increase 
in pro tein synthesis and intracellular accumulation of viral proteins (10). The capsid pro tein of 62 
Kd in molecular weight (cP62) is the most abundant product of this phase and is synthesized as a 
polypeptide o f 76 Kd which rapidly undergoes proteoly tic cleavage. Severa l o ther vi ral induced 
proteins with molecular weights of 96 Kd, 84 Kd, 39 Kd, 36 Kd and 27.5 Kd are also detected in the 
late phase. However, functions fo r these pro teins remain unknown. At the onset of cytopathic 
effect, two minor species of 70 Kd and 49 Kd in molecular weight are also detected (10). 
The capsid protein (cP62) is synthesized as a precursor of 76 Kd (cP76) and is not detected unless 
inhibitors of pro teolytic cleavage are added to infected cells. Under such conditions, and also at 
increased tempera tures (42° C), larger proteins, of 125 Kd, 123 Kd and 98 Kd are observed (10), 
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which may be the product of the four transcripts observed at this time (45). However, a clear 
maturation pathway of FCV induced polypeptides is sti ll unknown. Nevertheless, polypeptides of 
molecular weights of 96, 84, 75, 73, 70, 62, 49, 39, 36 and 27 KO appear to be final forms of viral-
induced polypeptides (10). 
The capsid protein 
The single capsid protein of FCV is a unique feature among animal viruses. The capsid protein 
gene is located at the 3' end of the viral genome (10, 46) and is transcribed from a full length 
negative sense genomic RNA (11) as a 2.4 to 2.7 Kb transcript, which may be detected as early as 2 h 
PI (11, 45). This early transcript is abundantly replicated and transcribed, which accounts for the 
rapid accumulation of the capsid protein in viral infected cells (45). The capsid genes for FCV 
isolates CFI/68 (46), F9 (12), F4 (76), KCD and NADC (62) have been cloned and sequenced , and the 
amino acid sequence for the capsid pro tein has been determined . 
The calicivirus capsid protein is hypothetically divided in six distinct regions designated A to F 
(44). The criteria used to define the borders was based on sequence homologies and the amount of 
amino acid sequence variability between each region. For FCV, the N-termini of the capsid 
precursor, which is cleaved from the final product, comprises region A. Region B extends from 
amino acids 121 to 396 and starts wi th the conserved FRLE-0 cleavage sequence. A s tretch of 5 
amino acids, 397 to 401 forms a sequence divergent region C, followed by a highly conserved region 
D, which extends from residues 402 to 425. Region E is highly variable and correspond to residues 
426 to 520, which most likely contains the serotype determinants. The carboxy-termini comprises 
the highly conserved region F (62). 
The overall amino acid sequence of the FCV capsid protein is highly homologous among different 
s trains. Using the capsid protein of s train NADC as a s tand ard, similarities of 88 to 91 % of the 
amino acid sequences are found among the 5 isolates (62). However, specific regions may have 
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higher or lower d egrees of homology. Specifically, the E region contains two sequence areas, from 
amino acids 426 to 458, and from amino acid 491 to 520 which diverge by 55 to 68% among isolates. 
At the center of these two regions, from amino acids 459 to 490, the sequence of amino acids is highly 
conserved among all isolates. Furthermore, amino acid residues 466 to 473 and 484 to 490 are highly 
hydrophobic and have a low surface probability, whereas the core of this region, from amino acids 
474 to 483 is hydrophilic and displays a high surface probability, as well as the remaining 
surrounding region, forming two pockets on region E (62). Such characteristics suggest antigenicity 
and interaction with cellular receptors. The surrounding hypervariable region would allow enough 
antigenic drift to evade the immune response but the interaction wi th cellu la r receptors would be 
guaranteed by the conserved amino acids underlying the pockets, as observed and described fo r 
other viruses (55). This hypothesis fits perfectly with the observation concerning the persistence 
of FCV in sites of low immunologic pressure in carrier cats and the variation in the antigenic 
spectrum among feline calicivirus (34, 38). 
Several neutralization epitopes have been identified in the FCV capsid protein distributed in 
fou r antigenic sites (13, 75). Interestingly, one epitope was conserved in all FCV strains tested and 
did not generate resistant variants as the o ther epitopes. Accordingly, such e pitopes had poor 
immunogenicity and may be critical for virus replication . It wou ld be of interest to identify the 
amino acids composing this epitope and its location on the capsid protein. Based on amino acid 
sequence analysis (62), it is likely that neutralizing epitopes are located in the variable region E, 
at the vicinity of the putative receptor binding sequence. Such studies wou ld provide valuable 
information regarding critical sequences necessary fo r stimulating the immune system, interaction 
with cellular receptors, uncoating mechanisms and viral assembly. 
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ABSTRACT 
The kinetics and biochemical properties of feline calicivirus (FCV) attachment to 
Crandell-Reese feline kidney cells were determined. Maximal binding was observed at pH 6.5 and 
was independent of the temperature. However, cells in suspension at 4°C bound virus more 
effi ciently than did cells in monolayers at 4°C or 37°C. High initial binding rate was observed 
either in mono layers or cells in suspension and proceeded to a maximum at 90 min, although half 
maximal binding was observed as early as 15 min. Binding was specific and competitively blocked 
by serotypically homologous or heterologous FCV as well as by San Miguel sea lion virus. 
Trea tment of cells with proteases increased FCV binding, whereas phospholipase had no effect on 
virus attachment. Conversely, cells trea ted with neuraminidase followed by 0-glycanase 
treatment showed a decreased binding ability. Cells of feline origi n bound FCV very efficiently, 
whereas non-permissive cells showed a poor binding ability. Following viral genomic RNA 
transfection, infectious virus could be recovered from all non-permissive cells, with the exception of 
Madin-Darby canine kidney cells. These results suggest that FCV binds selectively to cells 
expressing a specific receptor in which carbohydrates may be an important component of the 
attachment site and tha t FCV replication in non-permissive cells is primarily restricted by the 
absence of appropriate a ttachment sites on the cell surface. 
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INTRODUCTION 
Caliciviruses are a family of small non-enveloped viruses ranging in size from 35 to 40 nm in 
diameter that express a single major capsid protein of 60 to 70 Kilodaltons (Kd) (53, 54). 
Caliciviruses posses a positive-sense, non-segmented, polyadenylated RNA genome of 
approximately 7.69 Kb (12) to which a protein (VpG) is covalently attached to the 5' end (11). 
Members of the Caliciuiridae family include feline calicivirus (FCV), San Miguel sea lion virus 
(SMSV), vesicular exanthema of swine virus and rabbit hemorrhagic disease virus (48, 50, 52). 
Caliciviruses have also been identified in other animal species bu t a re not well characte rized (15, 
18, 19, 20, 24, 57, 58). 
No published information is available concerning the early interaction o f caliciviruses with cells 
in culture. The first s tep o f the viral infection cycle is interaction of the viral attachment protein 
wi th specific structures on the cell surface. These viral receptors are thoug ht to be the major 
determinants of tissue tropism (14, 21 , 22, 23, 29, 31, 38, 43, 47). Recently, however, it has been 
suggested that host range may also be virus related . Amino acid subs titutions can alter the 
glycosylation pattern of the influenza virus HA1 subunit hemagglutinin, changing its receptor 
binding properties. Accordingly, such changes result in an increased virus yield from partially 
resistant cells and would a llow virus host expansion in nature (5). The ability of certain poliovirus 
strains to infect mice may be determined by specific amino acids loca ted on the B-C loop of the VPl 
protein N-tenninus (46). Mutants of porcine parvovirus have their tissue tropism altered by a few 
amino acid substitutions o n the non-structural and capsid pro tein (61). Intracellular factors may 
also govern virus replication . Poliovirus infective cycle is restricted a t different steps after 
internalization by some Hela cells (34). Porcine parvovirus and gibbon ape leukemia virus 
replication and host range may be controlled by intracellular factors as well , rather than at the 
surface level (49, 51, 62). Receptor bind ing characteristics of some viruses have been reported (1, 3, 
9, 28, 37, 39, 63), and some virus receptors have been partially or extensively characterized 
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(2, 4, 8, 10, 13, 27, 30, 35, 44, 55, 59). Pursuant to these accomplishments, the interaction of FCV with 
a possible cellular receptor was investigated. In this study, we investigated the binding 
characteristics of FCV with feline cells and its interaction with various non-permissive cells in 
culture. 
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MATERIALS AND METHODS 
Cells and virus. Cra ndell-Reese feline kidney cells (CRFI<) (16) were grown in 490 cm2 roller 
bottles on Hank's minimal essential media (MEM) and supplemented with 5% fe tal bovine serum. 
Feline calicivirus (FCV) strain CFI/68 (17), and KCD (25) were obtained from American Type 
Culture Collection. The FCV s train NADC-1 was isolated from a cat at the Ames, Iowa, animal 
shelter (W.L.M.). To determine cell type tropism, various cell lines were obtained from the 
American Type Culture Collection o r the Cytology Group of the National Veterinary Services 
Labora tory (NVSL, Ames, IA). Cells examined were African green monkey Vero cells, canine A-72 
cells, porcine PK-15, murine EMF-P, canine MDCK, feline AK-D, feline Fc3Tg, feline FCWP, feline 
WWC a nd feline KKp. The KKp is a primary kitten kidney cell line propagated at the NVSL. 
The FCWP and WWC cells are primary whole embryo cell lines provided by Dr. Roger Woods of 
the Nationa l Animal Disease Center (NADC, Ames, IA). 
Virus purification. Feline calicivirus was propagated by infection of CRFK cells, replicated in 
490 cm2 roller bottles, at a multiplicity of infection of 10 PFU per cell. The virus was allowed to 
adsorb for 1 hr at 37°C. The inoculum was removed and 10 ml of scrum-free media were added, and 
incubation was continued at 37°C until cytopathic effect (CPE) was complete. To generate 
radioactively-labeled virus, CRFK cells were incubated in methionine-cysteine free Hanks MEM 
without serum. Trans 35-5 label (ICN Biomedicals, Inc.) containing radioactive methionine and 
cysteine was added to a concentra tion of 30 µCi / ml 4 hrs afte r infection with FCV strain CFI/68. 
Infected cells were harvested when cells detached freely from the flask s urface. The supernatant 
fluid was frozen and thawed twice to re lease virus particles, and the cell debris was removed by 
centrifugation a t 12,000 x g for 30 min a t 10°C in a Beckman JA-20 rotor. The supernatant was 
layered onto a step gradient containing 1 ml of 55% sucrose and 6 ml o f 27.5% sucrose, both of which 
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were prepared in R-buffer (10 mM Tris-hydrochloride [pH 7.2), 150 mM NaCl, 50 mM MgCl2) (1). 
The virus was banded at the 27.5:55 interface by centrifugation a t 100,000 x g for 2 hrs in a SW 40 
swinging bucke t rotor. The virus band fraction was collected, dialyzed overnight against R-buffer 
and layered over a linear density gradient of 1.28 to 1.44 g/ml of CsCl in R-buffer. Isopycnic 
banding of the virus was achieved by centrifugation at 150,000 x g for 18 hrs in a SW 40 rotor. The 
viral band was removed from the gradient and dialyzed against R-buffer for 18 hrs with three 
changes of the dialysate. For radioactively labeled virus, the g radient was fractionated from the 
bottom into 0.5 ml fractions, and 5 µI of each fraction was used for the determination of 
radioactivity by liquid scintillation counting. A second aliquot of 5 µl was removed from each 
fraction for slo t-blo t hybridization of vira l RNA as described (56). The density of each fraction 
was determined by refractometry (Fisher Scientific Co.) and infectivity p rofiles were performed 
across these gradients by plaque assay on 35 mm petri dishes. Purified virus was dialyzed against 
R-buffer and stored in al iquots at -70°C. Following purification, viruses were examined by e lectron 
microscopy. 
Virus quantification. The number of PFU/ml across the gradient was determined. Briefly, 100 µI 
of a tenfold dilution of each fraction was adsorbed on CRFK cells grown in 35 mm petri dishes. 
After 1 hr at 37°C, the inocula was removed, the cells washed, and 5 ml of 0.5% agarose in 
serum-free MEM layered on top. Incubation proceeded at 37°C for 36 to 48 hrs, after which plaques 
were visualized by staining the cells wi th crystal violet (0.02%). Because of the s imilarities 
between caliciviruses and picomaviruses, the number of virus particles stored in solution were 
determined by absorption at 259 nm in a 1 cm path using E 1 %/259 = 76 (6). 
Virus binding assay. Measurements of virus attachment were performed on monolayer or cells in 
suspension by a modifica tion o f the procedure described by Baxt et al. (9). 
Method 1. To determine binding of virus to monolayers, Crandell-Reese feline kidney cells were 
grown in 24 well plates to a concentration of approximately 8 x 105 cells/well. After removing the 
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media and washing the cells with serum-free MEM, 10 µI of MEM containing radioactively labeled 
virus were added. The multiplicity o f infection (particles/cell) used are indicated in the figures 
and legends. Plates were incubated at 4°C or other temperatures as indicated, and gently rocked 
every 10 min. At various times post infection (P.I.), the inoculum was removed and the plates 
washed with 0.5 ml of cold phosphate buffered saline (PBS). The intact cell monolayer was 
solubilized with 0.2 ml of PBS containing 1% Triton-X-1 00 and transferred to scintillation vials in 
which 1.5 ml of scintillation fluid were added . The extent of bound virus was determined in a 
Packard TRI-CARB 2200 CA liquid scintillation ana lyzer. All experiments we re repeated in 
triplicate on d ifferent days, and equivalent results were consistently obtained . 
Method 2. To determine binding of virus to cells in suspension, CRFK cells grown in 490 cm2 roller 
bottle were washed o nce with PBS and removed with 5mM EDTA in PBS without Ca2+ or Mg2+. 
After detachment, cells were washed once in MEM 5% calf serum, followed by two washes in cold 
serum-free MEM in which they were resuspended to a concentration of 5 x 107 cells/ml. Aliquots 
containing 5 x 105 cells were placed individua lly in 1.5 ml conical plastic tubes and centrifuged for 
5 sat 12,000 x g in a microcentrifuge. The superna tant was carefully removed, and the cells were 
resuspended in 20 µl of MEM containing radioactively labeled vi rus at concentrations indicated in 
the figure legends. Binding was allowed to occur a t 4°C, or as o therwise sta ted. The reaction was 
quenched at specific times by the addition of 0.2 ml of cold PBS and centrifugation at 12,000 x g 
for 5 s. The supernatant fluid was removed and a second wash step was performed. The pellet was 
collected as described for me thod 1. Binding o f radioactive FCV C FT/68 to o ther mammalian cells, 
as specified in results, was also assessed by the same method. 
Receptor saturability. To de termine the number of a ttachment sites to FCV on the cell surface, 
CRFK cells were prepared as described in method 2 and incuba ted with increasing amounts of 
radioactive virus. Bound radioactivity was de termined after incuba tion a t 4°C for 90 min. 
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Competition experiments. Cells were prepared as described in method 2 and incubated with 
20-fold excess of unlabeled homologous (CFf/68) o r serologically heterologous (KCD and NADC) 
FCV. San Miguel sea lion virus (53), a calicivirus from pinnipeds, and the non-enveloped 
parvovirus feline panleucopenia virus (FPV) (33) were also used in competition experiments. After 
incubation at 4°C fo r 90 min with non-radioacti ve virus, cells were pelleted, washed, and incubated 
with radioactively labeled virus for an additional hour a t 4°C. The amount of radioactively 
labeled virus bound was determined as described above. 
Transfection of cells. Viral genomic RNA was obtained as described previously (40). Aliquots 
containing 5 µg/ml were pelle ted and resuspended in 100 µI of OPTI MEM 1 (Gibco-BRL). For 
transfecti on, 20 µg of Lipofectin (Gibco-BRL) was diluted to a final volume of 100 µJ of OPTI MEM 1 
and mixed with the solu tion containing the viral RNA (26, 42). The mixture was gently vortexed 
a nd incubated on ice for 5-10 min when OPTI MEM 1 was added to a final volume of 1 ml. Confluent 
monolayers of cells on 24 well plates were washed twice with scrum-free MEM and incubated with 
OPTI MEM 1 for 15 min before transfection. The media was removed, and the cells transfected with 
200 µI/well of the RNA-Lipofectin preparation. After 3 hrs at 37°C, the inoculum was replaced by 
0.5 ml of serum-free MEM and incubation was allowed to proceed for 24-48 hrs (complete CPE on 
permissive cells). The supernatant was collected and viral progeny m easured by plaque assay. 
Lipoinfection u sing viral particles was also completed u sing a multiplicity of infection of 20 (7). 
After 2 hrs, the inocula was replaced by MEM containing anti FCV neutralizing polyclonal a ntisera 
at a dilution of 1:500 a nd incuba ted for 30 min. Control viral infections were conducted 
simultaneou sly without Lipofectin in each cell line, as described in Fig. 7. Viral progeny was 
measured by plaque assay as described . 
Enzyme treabnent of cells. To determine the nature of the FCV attachment site components, 
aliquots of cells in suspension were treated with the enzymes listed in Table 1 a t the specified 
conditions. Cells were then washed twice in MEM containing 2% fetal calf serum and 2 µM of 
25 
phenylmethylsulphonyl fluoride (PMSF) to inhibit the enzymes and the remaining binding ability 
was determined by incubating the cells with radioactively labeled virus for 60 min at 4°C. The 
cell-associated radioactivity in each treatment was measured and compared with untreated cells. 
Enzymes, chemicals, and isotopes. Translabeled 35-S me thionine/ cysteine was purchased from 
ICN Biomedicals, Inc. The following enzymes were purchased from Boehringer Mannheim 
Biochemicals: chymotrypsin, pronase, protcinasc K, neuraminidase, and papain. Trypsin, 
a-glycosidase, P-glycosidase, a-amylase, chondroitinase ABC Iyase, acylase, and 
phenylmethylsulfonyl fluoride (PMSF) were purchased from Sigma. Phospholipase A was 
obtained from Calbiochem-Behring Corp. 0-glycanase was purchased from Genzyme Corp. 
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RESULTS 
Virus puxification. Virus preparations used to examine the early interaction of FCV with CRFK 
cells were obtained from lysates of infected cells by two centrifugation steps through sucrose and 
CsCl, respectively. A predominant peak of radioactivity was observed in the CsCl fraction with a 
density of 1.37 g/ml (Fig. lA), which corresponded to the previously reported density of FCV virion 
(53). Higher virus titers were also observed in fractions having a peak of radioactivity, and 
slot-blot results clearly demonstrated a greater amount of viral RNA in these fractions (Fig. lA). 
Gel electrophoresis of radioactively labeled virus showed a single band of radioactivity (data not 
shown) corresponding to the single capsid protein of FCV. Viruses obtained by this method 
consisted of uniform and characteristic particles as demonstrated by electron microscopy (Fig. 1 B). 
A typical morphology consisting of small circular cup-shaped uniform particles were observed. 
Effect of pH on virus attachment. The effect of pH on the binding of FCV to CRFK cells was 
determined for a series of values between pH 5.0 and 9.0 (Fig. 2). Maximal binding of FCV was 
observed at pH 6.5, although there was no large difference in the binding abi li ty of the virus in the 
pH range between 6.0 and 8.0. Binding occurred to a lesser extent at pH 5.0 to 6.0 and decreased 
sharply at pH 9.0. The pH was maintained between 6.5 and 7.0 by using Hepes-buffered media for 
subsequent virus binding experiments. These results correlated well with those observed with 
plaque assays in which a maximal number of plaques was consistently observed at pH 6.0 (Fig. 2). 
Kinetics of FCV attachment to CRFK cells. Figure 3 illustrates the binding of 355 methionine 
labeled FCV strain CFI/68 to CRFK cells. Viruses readily associated with cellular receptors and 
half maximum of total binding was complete by 15 min. However, binding of FCV to cells in 
monolayers (method 1) occurred to a lesser extent than binding to cells in suspension (method 2). 
Adsorption of viruses occurred at a greater initial rate and to a greater extent at 4°C than a t 37°C. 
The percentage of virus binding to the cells increased progressively with time, independently of the 
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temperature. Cells in suspension at 4°C bound viruses more efficiently and a plateau was reached as 
soon as 30 min after virus addition to CRFK cells. 
Saturability of FCV binding. To determine whether FCV binding to CRFK cells was saturable, 
increasing amounts of radioactively-labeled CFl/68 were incubated with a constant number of 
CRFK cells in suspension by method 2. The number of viral particles which became cell associated 
increased linearly with viral input (Fig. 4). When expressed as a percentage of input, the amount 
of radioactivity bound was high for low multiplicities of infection and the relative amount bound 
decreased at higher multiplicities of infection. A plateau was reached at multiplicity of infection 
of approximately 1.5 to 3 x 103 virus/cell, indicating a finite number of receptors on the cell surface 
(Fig. 4). 
Specificity of FCV binding. To determine whether FCV attachment was specific and if different 
isolates of FCV share the same receptor, the ability of unlabeled FCV isolate CFl/68 to compete 
with 35-S labeled CFl/68 for a ttachment to CRFK cells was assessed (Fig. 5). Unlabeled FCV 
strains KCD and NADC, SMSV, and FPV were also assessed for their ability to block attachment 
of radioactively-labeled FCV CFI/68. The attachment of radiolabeled CFl/68 was inhibited by 
excess of homologous unlabeled virus (Fig. 5). Feline calicivirus isolates KCD and NADC were also 
able to reduce attachment of CFI/68 to a similar extent as the homologous virus. Interestingly, San 
Miguel sea lion virus 1 (SMSVl), a calicivirus from pinnipeds, was also able to prevent binding of 
CFI/68 to CRFK cells, even though it does not replicate in feline cells. Binding of FCV CFI/ 68 to 
CRFK cells was in no way affected by the presence of FPV. 
FCV cell tropism and replication in non-permissive cells. Cell tropism of FCV was assessed by 
incubation of radioactively-labeled virus with cells in suspension for 60 min at 4°C. The amount of 
bound virus is represented as percentage of virus input. FCV bound readily and efficiently to all 
feline cell lines tested (Fig. 6). Highest binding was observed with WWC and CRFK cells. 
Somewhat lower binding was observed with the feline tongue cells, Fc3Tg, and with the primary 
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cells, K.Kp and FCWP. Binding to the other mammalian cells could not be demonstrated at levels 
higher than background except MOCK cells, which bound FCV at approximately 30% that of 
CRFK cells (Fig.7 A). 
Viruses possessing a positive-sense RNA genome may replica te in cells Jacking specific receptors 
once they bypass the cell membrane barrier. To investigate the role of receptors on FCV replication 
and correlate it with FCV cell tropism, the cationic phospholipid Lipofectin was used to transfect 
a variety of non-permissive cells either with viral RNA or viral particles. CRFI< cells were used 
as a control for comparisons of viral progeny, which was measured by plaque assay. Virus yield in 
the various transfected cell lines were as specified in Fig. 7B. Viral replication, d etected by 
cytopathic effect (CPE), was readily observed in CRFK cells lipoinfected ei ther wi th viral RNA or 
viral particles, as well as in CRFK cells transfected with whole virus particles. Non-permissive 
cells transfected with viral RNA showed dispersed cells which rounded up and d e tached from the 
monolayer, except MOCK cells. Control non-permissive cells infected with virus only showed no 
CPE and viru s could not be recovered from the supernatant at 24 hrs P.I. (data not shown). 
Effect of enzymes on FCV binding. To d etermine the biochemical nature and possible components 
involved with the virus attachment site, CRFK cells in suspension were submitted to a variety of 
enzymatic treatments. The remaining binding ability was assessed and compa red with that of 
untreated cells. Cells, virus, a nd enzyme concentrations, as well as reaction conditions, were as 
specified in Table 1. Binding of FCV to CRFK cells was enhanced on cells treated with proteases 
(trypsin, chymotrypsin, proteinase K, pronase, and papain). Phospholipase A had no e ffect on 
virus binding. Glycosidases, except 0-glycanase, had little or no effect on FCV binding,. When 
CRFK cells were treated with neuraminidase followed by 0 -glycanase treatment, virus binding 
ability of the cells was reduced by approximately 30%. 
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DISCUSSION 
Specific macromolecules on the cell surface have been used by viruses to gain entrance into the 
cellular environment where they replicate. These macromolecula r receptors frequently are the sole 
barrier that restrict viral replication and tissue tropism. The virus-receptor inte raction is 
influenced to some extent by a variety of factors such as temperature, ion concentration, divalent 
cations, and electrical charges. No information regarding these early events of viral replication is 
available for caliciviruses. Furthermore, no information on the interaction of caliciviruses with 
non-permissive cells had been reported . 
The binding characteris tics of FCV to CRFK cells and its interactions with o ther mammalian 
cells were examined during this s tudy. The binding of FCV CFl/68 to CRFK cells occurred 
independently of the temperature, either in monolayers or cells in suspension. However, overall 
FCV binding was greater at 4°C. Similar results have been reported for foot-and-mouth disease 
(FM DV) (9), encephalomyocarditis virus (45), and mengo virus (41). Viruses a ttached to the cells 
progressively with time to a maximal binding rate of 40 to 60% depending on the method used. The 
initial binding ra te occurred rapidly, and half maximum of total binding was observed as early as 
15 min. Furthermore, cells in suspension bound virus at a grea ter initial rate than cells in 
monolayers, probably because more receptors on the cell surface arc available for interaction with 
the viral a ttachment protein. Lower binding observed with cells in monolayers a t 37°C may be 
accounted for by spontaneous virus elution a t the physiological temperature. 
The rate o f FCV attachment to CRFK cells was apparently highly dependen t on diffusion. When 
the volume of the binding media was increased, but not the virus or cell concentration, the ra te of 
a ttachment decreased significan tly, lowering the overall slope of the a ttachment curve. The 
interaction of FCV and cellular receptors was a lso dependent on divalent ca tions. Increasing 
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concentrations of EDTA greatly reduced the percentage of virus that became cell-associated (data 
not shown). 
Binding of FCV to CRFK cells did not vary significantly from pH 6.0 to 8.0, but was slightly 
lower at pH values of 5.0 to 6.0. Maximaland minimal binding was observed at pH 6.5 and 9.0, 
respectively. Similar pH dependence on the interaction of virus and cell receptors were also 
observed for FMDV (9), rabies virus (63), and simian virus 40 (13). Furthermore, the ability of FCV 
to form plaques on a plaque assay was consistently higher on cells held at pH 6.0 during the 
adsorption period. 
It was demonstrated in this study that FCV exhibits specific saturable binding to CRFK cells. 
The number of attachment sites was estimated from the relationship between input multiplicity 
and attachment of specific amounts of radioactive virus. Approximately 1.5 to 3 x 103 virus 
particles bound to CRFK cells. The adsorption curve indicated tha t the efficiency of attachment 
reached a plateau after 1.6 x 103 virus particles had been adsorbed to cells. The number of binding 
sites observed in this study correlates well with data reported for other virus-cell systems (9, 36, 
63). Sca tchard analyses of the binding data were no t performed in tha t it assumes a monovalent 
interaction of ligand and receptor, which is most likely not the case with FCV. It has been 
assumed and extensively reported that viruses from the same group share or compete for the same 
receptor site on permissive cells (9, 28, 60, 63) . Similarly, our experiments have demonstrated that 
different FCV isolates bound to the same receptor on the CRFK cell surface. Small differences were 
observed in the ability of different FCV virus isolates to compete for the same attachment si tes. It 
is assumed, therefore, that FCV binding has a specific requirement for receptor-mediated 
interaction with cells. Non-specific binding observed in the presence of an excess of unlabeled 
homologous virus averaged approximately 10% and is thought not to lead to the normal infective 
pathway. Surprisingly, SMSV 1 prevented FCV from binding to cells in culture even though CRFK 
cells are non-permissive to SMSV 1. Conversely, FCV did not bind to Vero cells, in which SMSV 1 
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replicates, suggesting that SMSV 1 may recognize a related receptor on CRFK cells. No efforts were 
made to determine SMSV 1 internalization on CRFK cells. Reciprocal experiments were not carried 
out and the binding characteristics of SMSV will be investigated in future studies. Binding of FCV 
to CRFK cells was in no way abolished by the presence of FPV, an unrelated non-enveloped virus. 
Binding of FCV was observed with all feline cells tested. Differences observed on the percentage 
of attachment to an individual cell type may reflect the number and distribution of the attachment 
sites on the cell surface. FCV binding to non-permissive mammalian cells occurred to a lesser extent 
and any binding may be non-specific, leading to a nonproductive infection. However, MOCK cells 
showed a higher binding ability, but no attempts were made to assess binding specificity or virus 
internalization. 
Viral replication in non-permissive cells may be restricted by the absence of specific receptors on 
the cell surface and lack of virus internalization or viral uncoating. Such inhibition of replication 
may be overcome by transfecting non-permissive cells with viral particles or with viral genome. 
The preformed liposome, Lipofectin, has been used to bypass the membrane lipid bilayer, 
delivering virus particles (7, 32) or nucleic acids into cells (26, 42), greatly improving the 
understanding of the early events on the virus infectious cycle. To address the question of receptor 
specificity and its relationship with tissue tropism, FCV particles and FCV RNA were transfected 
into permissive and non-permissive cells. Our results showed that the positive sense RNA of FCV 
could be replicated once it reached the cell translation system of the non-permissive cells. Cells 
transfected with viral particles provided simila r results (data not shown). However, viral 
progeny could not be recovered from MDCK-transfected cells, which was the sole non-permissive 
cell line that bound virus to a larger extent. Such cells probably restricted viral replication at the 
transla tion or post-translational level, rather than at the receptor level as observed for the 
remaining non-permissive cells. Such information emphasizes the importance of receptors and 
intracellular factors on viral replication, tissue tropism, and pathogenesis. 
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Information on the biochemical nature of viral attachment sites is commonly sought by 
determining the effect of enzymatic treatment of cells on virus binding. Binding assays were 
completed on CRFK cells treated with a variety of d ifferent enzymes. The results of these assays 
suggest that a carbohydrate moiety may be an important component of the attachment site. The 
enzyme 0-glycanase, with specifically removes the Gal-IS (1, 3) GalNac core disaccharides from 
serine and threonine residues of glycoproteins, reduced FCV binding to CRFK cells by 
approximately 30%. Neuraminidase treatment of the cells prior to the addition of 0 -glycanase is 
recommended to remove potential inhibitors of 0-glycanase such as N-acetyl neuraminic acid, a 
common substituent of 0-linked carbohydrates. Treatment of cells with 0-glycanase alone had no 
effect on FCV binding. Further evidence for the involvement of carbohydrates on the attachment 
site for FCV came from studies wherein sodium pcriodate treated cells had a reduced binding 
ability (data not shown). Interestingly, a variety of other small non-enveloped viruses have been 
shown to require 0-linked sugar residues for adequate ligand binding (8, 13, 28, 29). 
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Table 1. Effect of enzymatic treatment of CRFK cells on FCV binding 
to CRFK cells in culture 
Enzyme C.onc 
% binding compared 
with control 
None 
Phospholipase Aa 
Trypsinb 
Chymotrypsinb 
Proteinase Kb 
Pronaseb 
Papainc 
Neuraminidased 
a-glucosidasee 
P-glucosidasee 
a-amylasee 
0-glycanasef 
Chondroitinase ABC lyasee 
Acy la see 
a Reaction conditions; pH 7.5, 25°C, 30 min 
bReaction conditions; pH 7.5, 25°C, 15 min 
cReaction conditions; pH 5.5, 25°C, 15 min 
dReaction conditions; pH 5.0, 25°C, 60 min 
eReaction conditions; pH 7.0, 37°C, 60 min 
200 µg/ ml 
50µg/ml 
100 µg/ ml 
50µg/ml 
25 u / ml 
200 µg/ml 
400mU/ml 
100 µg/ml 
1 mg/ ml 
100µg/ml 
2mU/ml 
1 u /ml 
100 µg/ml 
fCells were treated with 400 mU of neuraminidase per ml at pH 5.0, 25°C 
60 min prior to the treatment with 0 -glycanase at pH 6.8, 37°C, 2 h . 
Buffer: a,b,c,dserum-free MEM; ePBS; f2Q mM sodium phosphate. 
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Figure 1. Feline calicivirus purification for virus binding assays. (A} (355]-methionine labeled 
feline calicivirus serotype CFI/68 was propagated as described in the text and purified by 
through CsCl linear gradient (1 .28 to 1.44 g/ cc). Fractions of 0.5 ml were collected from 
the bottom to the top. A portion of each fraction was analyzed by liquid scintillation 
spectrometry (-o-} or infectivity ( - •- ). Slot blot analysis of each fraction is depicted 
below the fraction number. Density determination on the gradient fractions containing the 
virus particles were accomplished as described in the text. Infectivity titrations were 
performed as described in the text. (B} Electron micrograph of FCV particles purified as 
described in panel A from fractions 4, 5, and 6. 
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Figure 2. Effect of pH on FCV binding and plaque formation. Cells in suspension were incubated at 
the indicated pH at 4°C with saturable amounts of radioactively-labeled virus. After 1 
hr, cells were rinsed and associated radioactivity was determined as d escribed in the 
text. For plaque formation, monolayers of CRFK cells were preincubated for 15 min with 
MEM and further incubated with virus for 1 hr at the indicated pH at 37°C. Petri dishes 
were overlaid with MEM 0.5% agarose and incubated at 37°C. Values indicated are 
average of two or more experiments. 
(-•-) % of maximum cpm bound. 
(~ ) Number of plaques x 107. 
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Figure 3. Kinetics of FCV attachmen t to CRFK cells. Radioactively labeled FCV serotype CFI/68 
was bound to CRFK cells in suspension at 4°C (-o- ), in monolayers at 4°C ( -0- ) or in 
monolayers a t 37°C (-•-). The reaction was quenched at each time point by washing 
the cells with cold MEM. The cell-associated radioactivity was measured by liquid 
scintillation spectrometry and is expressed as a percentage of total input. Resu lts are 
average of two or more experiments. 
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Figure 4. Number of putative a ttachment sites fo r FCV on CRFK cell s. An increasing number of 
radioactive ly-labeled FCV particles were added to a constant number of cell s (5 x 105 
cells) in suspension . After 90 min at 4°C, cells were washed twice and cell-associated 
radioactivity was determined. The number of bound virus was estimated as a percentage 
of to tal input. 
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Figure 5. Competition binding experiments among caliciviruscs. CRFK cells in suspension (5 x 105 
cells) were allowed to react with an excess (1 x 109 particles) of homologous <CFI/68) or 
heterologous (KCD, NADC) unlabeled virus for 90 min at 4°C. A related calicivirus from 
pinnipeds, San Miguel sea lion virus (SMSV), and the non-enveloped fe line parvovirus 
(FPV) were also used in competition experiments. Radioactively-labeled virus was 
added after washing cells twice with cold MEM, and allowed to react for addi tional hr at 
4°C. Cell-associated radioactivi ty was estimated as a percentage of total input and 
represents the average ± S EM of two or more experiments. 
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Figure 6. Binding of FCV to different cells of feli ne origin. Cells in suspension (5 x HP cell s) were 
a llowed to react with 1 x 108 vi rus parh cles at 4°C for 60 mm. Cells were rinsed, and 
associated radioactivity was de termined by liquid scintillation spectrometry. Va lues 
indicated are in percentage of to tal input and represent the average ± SEM of two or more 
experiments . 
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Figure 7. Feline calicivirus interaction with non-permissive ceJls. (A) Cells in suspension (5 x 105 
cells) were allowed to react with radioactively-labeled FCV CFI/68 at 4°C for 1 hr. 
Cell-associated radioactivity was determined after washing the cells twice with cold 
MEM. Results are represented as percentage of total input and are the average± SEM of 
two or more experiments. (B) Monolayers of cells in 24-well plates were transfected with 
viral RNA as described in the text. Virus yield was measured by standard plaque assay 
procedures on monolayers of CRFK ceJls grown in 35 mm petri dishes. 
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GENERAL SUMMARY 
Feline calicivirus is widespread in the cat population in which it causes an upper respiratory 
disease. The study of the molecular biology of feline calicivirus has been updated mainly because 
of the relatively little information which was available concerning caliciviruses. Feline 
calicivirus has been used as a model for the Caliciviridae family which also includes San Miguel 
sea lion virus (SMSV), vesicular exanthema of swine virus (VESV), and rabbit hemorrhagic 
disease virus (RHDV). 
The study of the molecular biology of a virus group usually overlooks the early events of the virus 
replicative cycle. The first step leading to a productive viral infection is the interaction o f the 
viral attachment protein with specific molecules on the cell surface, acting as virus receptors. The 
concept of "receptor" implies the interaction between two entities and has been misused in 
experimental virology. Rather, the term virus receptor site should be applied, in that it defines 
the interaction of a virus with a specific region on the cell surface composed of many molecules. 
This view is mainly supported by the nature o f the virus surface structure, composed o f repeated 
molecules with the potential o f multivalent interactions. This is specifically true fo r FCV, and the 
term virus receptor si te has been used in this dissertation. 
The early events of FCV interaction with CRFK cell s was investigated with the main objective 
of further the understanding of calicivirus tissue tropism, replication and pathogenesis. Feline 
calicivirus interaction with receptor sites was optimized at mild acidic conditio ns and occurred 
independently of the temperature. Following a high initial binding rate, the association of virus 
with cells proceeded slowly up to 90 minutes, which reflects a lower receptor si te availability 
after a short period of time. Binding of FCV to CRFK cells was specific and competitively blocked 
by homologous virus, a primary requirement fo r ligand-receptor interaction. Biochemically, the 
receptor a ttachment si te for FCV may possess carbohydrates moieti es which play an important 
role in the interaction with the vi ral attachment protein. Receptor si tes fo r FCV were observed in 
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various cells of feline origin which bound virus very efficiently and supported viral replication. 
Binding of FCV was also observed with a non-permissive cell line, MOCK, althoug h to a lesser 
extent than to feline cells. Binding to other non-permissive cells occurred at levels no t higher than 
10%, which is considered non-specific, and may lead to a non-productive infection. The role a 
specific receptor attachment site plays in ti ssue tropism and viral replica tion was demonstrated by 
transfecting non-permissive cells with viral genom ic RNA, which is infectious per se. 
Interestingly, MOCK cells did not support vi ral replication even though it bound virus quite 
efficiently. However, infectious virus could be recovered from the o ther non-permissive cells, 
demonstrating that FCV replication in non-permissive cells is mainly restricted by the absence of 
at tachment sites on the cell surface rather than by intracellular factors. 
Following speci fic binding, viruses are internalized, uncoated and the virus genome replicated. 
The intracellular pathway of FCV infectious cycle is currently being investigated to further the 
unde rs tanding of the various stages associated with virus replication. Evidence suggests that 
caliciviruses require passage through acidic endocytic vesicles for proper uncoating and replication. 
The role of an acidic environment or enzymes activated by acidic pH in FCV uncoating will be 
fu rther investigated . Future work with FCV will also be directed towards determining the 
nucleotide sequence of the capsid gene and the amino acid sequence of the capsid p rotein o f a series 
of variant progeny vi rus isola tes that o rigina ted from a single parental strain, after persistent 
infection in the host. Such studies will be helpful in the understanding of virus mutation during 
replication under low immunologic pressure, and in the determination o f amino acid sequences 
composing epitopic regions of the capsid protein. Data obtained from these studies may be used for 
the formulation of peptides or multivalent vaccines in substitu tion of the curren t monovalent types, 
which may no longer provide good immunization. 
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